Respiratory Flashcards
List 8 important risk factors for PE in the ED patient
Most important risk factors in ED patients • OR > 2 • previous VTE • unilateral leg swelling • surgery in previous 4 weeks • oestrogen therapy • SpO2 < 95% on air • non cancer related thrombophilia • Trauma: 25% of PEs occur within 4 days of injury, 50% within one week
In order of frequency, what are the top 7 most common symptoms in PE?
Dyspnoea Pleuritic chest pain Apprehension Cough Haemoptysis Sweats Syncope Non pleuritic chest pain
What percentage of patients with symptomatic PE have no identifiable risk factors?
50%
What are the Right Heart signs of PE?
(usually only present with large PE)
•loud pulmonary closure sound •wide splitting of second heart sound •right ventricular gallop •right ventricular heave • elevated JVP - prominent a waves on JVP •localised rales, rhonchi, rub
State the 5 severity grades for PE
I - minimal symptoms II - tachypnoea, tachycardia III - hypotension, fluid responsive IV - hypotension, needing pressor support V - needing cardiopulmonary support
Define massive, submassive and non massive PE. State their short term mortality.
Massive (High risk): Short Term mortality >15%
Haemodynamic instability with signs of shock. Persistent hypotension (SBP <90mmHg or drop > 40mmHg from baseline SBP for longer than 15mins)
Submassive (Intermediate risk): S/T mortality 3-15%
Signs RV dysfunction or and or myocardial necrosis
- Echo - RV dilation/dysfunction. LV ‘D sign’
- CT RV dysfunction (RV:LV ratio >0.9)
- RHS on ECG
- BNP >90
- Trop I > 0.4
Non-massive (low risk): S/T Mortality <3%
- no HD instability, normal BP
- no signs RV dysfunction or myocardial necrosis
Antimicrobial + dose for fungal infection
IV/PO Fluconazole 12mg/kg OD day 1 then 6mg/kg OD subsequently (systemic candidiasis, cryptococosis, prevention candida in immunocomprimised)
IV/PO fluconazole 6mg/kg OD for oral candidiasis
Amphotericin B
Severe systemic fungal infections
Adult, IV 3–5 mg/kg once daily; use the higher end of the dose range for CNS disease and fusariosis.
Child >1 month, IV, start at 1–3 mg/kg once daily; may increase up to 5 mg/kg once daily.
Empirical treatment in febrile neutropenia unresponsive to antibacterials:
Adult, child >1 month, IV 3 mg/kg once daily. Use 5 mg/kg once daily if mucormycosis suspected; seek specialist advice.
Define massive haemoptysis.
At what volume is the mortality 20-50%?
Blood volume 100-1000ml/24 hours
300-600mls/24hours = 20-50% mortality
Define exanguinating haemoptysis.
What is it’s mortality?
> 150mls/ 1 hour, and loss >1000mls
mortality 75%